← Insider buys
CRBP

Corbus Pharmaceuticals Holdings, Inc. · Healthcare

Director John Kenneth Jenkins sold $38K of Corbus Pharmaceuticals Holdings, Inc.

Sold$37,986
$7.91Price
4,800Shares
−56%Stake

What CRBP did after the filing

Filed Jun 11Copier in Jun 12
The stock from Fri, Jun 12 open, $7.74
+17.4%
S&P 500, same days
0.0%

Measured over 30 trading days, to the Jul 28 close.

Traded Wed, Jun 10. Filed Thu, Jun 11, 4:30 PM ET, after the close. Returns use the Jun 12 open and the Jul 28 close. Not investment advice.